浙江贝得药业有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
18
NMPA:18
Drug Approvals
Lacidipine Dispersible Tablets
- Product Name
- 拉西地平分散片
- Approval Number
- 国药准字H20130129
- Approval Date
- Jul 14, 2023
NMPA
Omeprazole Sodium for Injection
- Product Name
- 注射用奥美拉唑钠
- Approval Number
- 国药准字H20084263
- Approval Date
- Mar 14, 2023
NMPA
Azithromycin Dispersible Tablets
- Product Name
- 阿奇霉素分散片
- Approval Number
- 国药准字H20083280
- Approval Date
- Oct 23, 2022
NMPA
Azithromycin for Injection
- Product Name
- 注射用阿奇霉素
- Approval Number
- 国药准字H20073769
- Approval Date
- May 25, 2022
NMPA
Famotidine for Injection
- Product Name
- 注射用法莫替丁
- Approval Number
- 国药准字H20073889
- Approval Date
- May 25, 2022
NMPA
Azithromycin for Injection
- Product Name
- 注射用阿奇霉素
- Approval Number
- 国药准字H20073770
- Approval Date
- May 25, 2022
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found